Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients

Summary

This study is a randomized, double-blind, placebo-controlled single-center clinical trial. The aim of this study is to investigate the efficacy and safety of low-dose telitacicept for prevention of flares in SLE patients with low disease activity.

Timeline

Start

2024-06-28

Primary completion

2027-06-30

Completion

2027-06-30

Drugs

Indications